Toll Free: 1-888-928-9744
Published: Apr, 2014 | Pages:
28 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Laboratorios Farmaceuticos Rovi, S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Laboratorios Farmaceuticos Rovi, S.A. - Product Pipeline Review - 2014', provides an overview of the Laboratorios Farmaceuticos Rovi, S.A.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios Farmaceuticos Rovi, S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Laboratorios Farmaceuticos Rovi, S.A. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Laboratorios Farmaceuticos Rovi, S.A.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Laboratorios Farmaceuticos Rovi, S.A.'s pipeline products Reasons to buy - Evaluate Laboratorios Farmaceuticos Rovi, S.A.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Laboratorios Farmaceuticos Rovi, S.A. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Laboratorios Farmaceuticos Rovi, S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Laboratorios Farmaceuticos Rovi, S.A. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios Farmaceuticos Rovi, S.A. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Laboratorios Farmaceuticos Rovi, S.A. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Laboratorios Farmaceuticos Rovi, S.A. Snapshot 5 Laboratorios Farmaceuticos Rovi, S.A. Overview 5 Key Information 5 Key Facts 5 Laboratorios Farmaceuticos Rovi, S.A. - Research and Development Overview 6 Key Therapeutic Areas 6 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products Glance 10 Laboratorios Farmaceuticos Rovi, S.A. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Laboratorios Farmaceuticos Rovi, S.A. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Laboratorios Farmaceuticos Rovi, S.A. - Drug Profiles 12 ardeparin sodium 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 risperidone 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 letrozole 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 olanzapine 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 paliperidone 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 RO-17 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Analysis 19 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Target 19 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Route of Administration 20 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Molecule Type 21 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Mechanism of Action 22 Laboratorios Farmaceuticos Rovi, S.A. - Recent Pipeline Updates 23 Laboratorios Farmaceuticos Rovi, S.A. - Dormant Projects 24 Laboratorios Farmaceuticos Rovi, S.A. - Locations And Subsidiaries 25 Head Office 25 Other Locations & Subsidiaries 25 Appendix 27 Methodology 27 Coverage 27 Secondary Research 27 Primary Research 27 Expert Panel Validation 27 Contact Us 28 Disclaimer 28
List of Tables Laboratorios Farmaceuticos Rovi, S.A., Key Information 5 Laboratorios Farmaceuticos Rovi, S.A., Key Facts 5 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Indication, 2014 7 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Stage of Development, 2014 8 Laboratorios Farmaceuticos Rovi, S.A. - Monotherapy Products in Pipeline, 2014 9 Laboratorios Farmaceuticos Rovi, S.A. - Phase II, 2014 10 Laboratorios Farmaceuticos Rovi, S.A. - Preclinical, 2014 11 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Target, 2014 19 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Route of Administration, 2014 20 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline by Molecule Type, 2014 21 Laboratorios Farmaceuticos Rovi, S.A. - Pipeline Products by Mechanism of Action, 2014 22 Laboratorios Farmaceuticos Rovi, S.A. - Recent Pipeline Updates, 2014 23 Laboratorios Farmaceuticos Rovi, S.A. - Dormant Developmental Projects,2014 24 Laboratorios Farmaceuticos Rovi, S.A., Other Locations 25 Laboratorios Farmaceuticos Rovi, S.A., Subsidiaries 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.